Comparing Pervasip (OTCMKTS:PVSP) and USANA Health Sciences (NYSE:USNA)

USANA Health Sciences (NYSE:USNA) and Pervasip (OTCMKTS:PVSP) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, dividends and risk.

Volatility and Risk

USANA Health Sciences has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Pervasip has a beta of -0.32, indicating that its stock price is 132% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for USANA Health Sciences and Pervasip, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	0	1	0	0	2.00
Pervasip	0	0	0	0	0.00

USANA Health Sciences currently has a consensus price target of $35.00, indicating a potential downside of 8.28%. Given USANA Health Sciences’ stronger consensus rating and higher possible upside, research analysts plainly believe USANA Health Sciences is more favorable than Pervasip.

Earnings & Valuation

This table compares USANA Health Sciences and Pervasip”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$861.97 million	0.84	$63.79 million	$2.83	13.48
Pervasip	$15.77 million	0.09	-$2.35 million	N/A	N/A

USANA Health Sciences has higher revenue and earnings than Pervasip.

Insider and Institutional Ownership

54.3% of USANA Health Sciences shares are owned by institutional investors. 0.3% of USANA Health Sciences shares are owned by company insiders. Comparatively, 9.2% of Pervasip shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares USANA Health Sciences and Pervasip’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	6.30%	10.64%	8.48%
Pervasip	-16.98%	N/A	-21.52%

Summary

USANA Health Sciences beats Pervasip on 10 of the 11 factors compared between the two stocks.

About USANA Health Sciences

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

About Pervasip

Pervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York.